SCHEMBL5521085

SCHEMBL5521085

O=[N+]([O-])C[C@@H](O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.67
NPC1 O15118 2/20 0.51
ADAM17 P78536 1/20 0.51
CPA1 P15085 3/20 0.49
LMNA P02545 1/20 0.48
BCAT2 O15382 1/20 0.47
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GSR P00390 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
AOC3 Q16853 3/20 0.44
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256630 1.00 ALDH1A1 (0.67) ALDH1A1NPC1ADAM17CPA1LMNA
SCHEMBL1348353 1.00 ALDH1A1 (0.67) ALDH1A1NPC1ADAM17CPA1LMNA
SCHEMBL17977235 0.89 ALDH1A1 (0.64) ALDH1A1NPC1ADAM17CPA1LMNA
SCHEMBL27807830 0.82 ALDH1A1 (0.70) ALDH1A1NPC1LMNAKDM4EMAPT
SCHEMBL27807831 0.82 ALDH1A1 (0.70) ALDH1A1NPC1LMNAKDM4EMAPT
SCHEMBL9202581 0.80 NPC1 (0.56) ALDH1A1NPC1ADAM17CPA1KDM4E
SCHEMBL2461328 0.80 ALDH1A1 (0.68) ALDH1A1NPC1LMNAKDM4EMAPT
SCHEMBL4242515 0.80 ALDH1A1 (1.00) ALDH1A1NPC1LMNAKDM4EMAPT
SCHEMBL2461281 0.80 ALDH1A1 (0.68) ALDH1A1NPC1LMNAKDM4EMAPT
SCHEMBL11947918 0.80 ALDH1A1 (0.62) ALDH1A1NPC1CPA1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2555625-B1 PROCESS FOR PREPARING BENZOXABOROLES GLAXOSMITHKLINE LLC (US) 2018-11-14 EP disclosed
US-20160168168-A1 PROCESS FOR PREPARING BENZOXABOROLES GLAXOSMITHKLINE LLC 2016-06-16 US disclosed
US-9243003-B2 Process for preparing benzoxaboroles GLAXOSMITHKLINE LLC (US) 2016-01-26 US disclosed
CN-104311424-A Optically pure beta-nitroalcohol derivatives and synthesis method thereof JINGCHU UNIVERSITY OF TECHNOLOGY 2015-01-28 CN disclosed
US-8557726-B2 Chiral heterogeneous catalyst for assymmetric nitroaldol reaction COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-10-15 US disclosed
US-20130096333-A1 Chiral Heterogeneous Catalyst for Assymmetric Nitroaldol Reaction COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-04-18 US disclosed
US-20130035501-A1 PROCESS FOR PREPARING BENZOXABOROLES GLAXOSMITHKLINE LLC (US) 2013-02-07 US disclosed
US-7205425-B2 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof CHISSO CORPORATION (JP) 2007-04-17 US disclosed
US-20070060656-A1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof SHIBASAKI MASAKATSU 2007-03-15 US disclosed
WO-2005073389-A1 METHOD FOR PRODUCING β-HYDROXY NITRO COMPOUNDS MADE FROM ALDEHYDES AND NITROALKANES WHILE USING A HYDROXY NITRILE LYASE ANGEWANDTE BIOKATALYSE-KOMPETENZZENTRUM GMBH (AT) 2005-08-11 WO disclosed
US-20050148801-A1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof JNC CORPORATION (JP) 2005-07-07 US disclosed
EP-0947498-B1 OPTICALLY ACTIVE NITRO ALCOHOL DERIVATIVES, OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVES, AND PROCESS FOR PREPARING THE SAME CHISSO CORP (JP) 2004-09-15 EP disclosed
US-6632955-B1 Optically active 1-substituted phenyl-2-nitro alcohol derivatives which are useful pharmaceutical intermediates. Enantiomotphs active 1-substituted phenyl-2-nitro alcohol derivatives. From these nitro alcohol such as albutramin and CHISSO CORPORATION (JP) 2003-10-14 US disclosed
US-20020193447-A1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof JNC CORPORATION (JP) 2002-12-19 US disclosed
EP-0947498-A1 OPTICALLY ACTIVE NITRO ALCOHOL DERIVATIVES, OPTICALLY ACTIVE AMINO ALCOHOL DERIVATES, AND PROCESS FOR PREPARING THE SAME CHISSO CORPORATION (JP) 1999-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148801-A1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof ADH1A, ALDH7A1, ADRB1 ALDH1A1 29/4885NPC1 2041/4885ADAM17 3274/4885
US-20130035501-A1 PROCESS FOR PREPARING BENZOXABOROLES CYP1B1, SULT1A1, HAX1 ALDH1A1 159/4885NPC1 969/4885ADAM17 3737/4885
US-20160168168-A1 PROCESS FOR PREPARING BENZOXABOROLES CYP1B1, SULT1A1, HAX1 ALDH1A1 159/4885NPC1 969/4885ADAM17 3737/4885
US-20070060656-A1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof ADH1A, ALDH7A1, ADRB1 ALDH1A1 29/4885NPC1 2041/4885ADAM17 3274/4885
US-20020193447-A1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof ADH1A, ALDH7A1, SARM1 ALDH1A1 24/4885NPC1 2121/4885ADAM17 3463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.